GNS-3545
/ Oscotec, Genosco
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 18, 2026
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=63 | Completed | Sponsor: Genosco Inc. | Recruiting ➔ Completed | Trial completion date: Oct 2026 ➔ Jun 2026
Trial completion • Trial completion date • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
November 07, 2025
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=72 | Recruiting | Sponsor: Genosco Inc.
New P1 trial • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1